This section summarizes biopharmaceutic studies and associated analytical methods.

This section should offer the reviewer a comprehensive overview of the formulation development process, the performance of the dosage form both in vitro and in vivo, and the overall strategy and rationale behind the development of the bioavailability (BA), comparative BA, bioequivalence (BE), and in vitro dissolution profile database.

Read the full ICH guidance.